<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03151018</url>
  </required_header>
  <id_info>
    <org_study_id>HOST-ONYX</org_study_id>
    <nct_id>NCT03151018</nct_id>
  </id_info>
  <brief_title>Effect and Efficacy of Onyx™, Zotarolimus-eluting Stent for Coronary Atherosclerosis</brief_title>
  <acronym>HOST-ONYX</acronym>
  <official_title>Harmonizing Optimal Strategy for Treatment of Coronary Atherosclerotic Lesions - Registry-based Study on the Effect and Safety of Onyx™, Zotarolimus-eluting Stent for Coronary Atherosclerotic Lesions: HOST-Onyx Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of this study are

        1. To establish a prospective registry of the whole patients who received percutaneous
           coronary intervention with Resolute Onyx™ stent.

        2. To evaluate the long-term efficacy and safety of coronary stenting with the Resolute
           Onyx™ stent.

        3. To compare the long-term efficacy and safety of coronary stenting between the Resolute
           Onyx™ stent and other contemporary drug-eluting stents which had established their own
           registry.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Secondary endpoints are

        1. Stent thrombosis-24 hours(acute), 30 days(subacute), 1 year(late), every 1 year till 3
           years(very-late) after index PCI (percutaneous coronary intervention),

        2. Target vessel failure

        3. Composite rate of cardiac death and any MI, 3 years

        4. Composite rate of all death and any MI

        5. Composite rate of all death, any MI, and any repeat revascularization

        6. Compliance and therapy interruptions with prescribed adjunctive antiplatelet therapy

        7. Clinical device and procedural success
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">May 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Target lesion failure</measure>
    <time_frame>12 months</time_frame>
    <description>Composite of cardiac death, non-fatal target vessel-related myocardial infarction (MI), and ischemia-driven target lesion revascularization (TLR)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stent thrombosis, acute</measure>
    <time_frame>within 24 hours after index PCI</time_frame>
    <description>according to Academic Research Consortium (ARC) definition</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent thrombosis, subacute</measure>
    <time_frame>from 24 hours to 30 days after index PCI</time_frame>
    <description>according to ARC definition</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent thrombosis, late</measure>
    <time_frame>from 30 days to 1 year after index PCI</time_frame>
    <description>according to ARC definition</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent thrombosis, very-late</measure>
    <time_frame>1 year ~ up to 3 years</time_frame>
    <description>according to ARC definition</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target vessel failure</measure>
    <time_frame>12 months</time_frame>
    <description>Composite of cardiac death, non-fatal target vessel related myocardial infarction, and ischemia-driven target vessel revascularization (TVR)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite rate of cardiac death and myocardial infarction</measure>
    <time_frame>12 months, 3 years</time_frame>
    <description>as title</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite rate of all-cause death and any myocardial infarction</measure>
    <time_frame>12 months, 3 years</time_frame>
    <description>as title</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite rate of all-cause death and any myocardial infarction, and any repeat revascularization</measure>
    <time_frame>12 months, 3 years</time_frame>
    <description>as title</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of compliance and interruptions with prescribed adjunctive antiplatelet therapy</measure>
    <time_frame>12 months, 3 years</time_frame>
    <description>we will estimate this outcome with relevant questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical device and procedural success rate</measure>
    <time_frame>intraoperative ( index PCI)</time_frame>
    <description>device success : residual stenosis &lt;30%, final thrombolysis in myocardial infarction (TIMI) flow grade III procedural success : device success + no adverse events immediate after the procedure</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">4000</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Acute Coronary Syndrome</condition>
  <condition>Myocardial Infarction</condition>
  <condition>Angina Pectoris</condition>
  <arm_group>
    <arm_group_label>Onyx</arm_group_label>
    <description>The patients who received PCI with Resolute Onyx stent(s)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Resolute Onyx</intervention_name>
    <arm_group_label>Onyx</arm_group_label>
    <other_name>Zotarolimus-eluting stent</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All coronary arterial disease patients who received percutaneous coronary intervention with
        Resolute Onyx™ stent(s)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age above 19

          -  Patients who received PCI with Resolute Onyx™ stent(s)

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hyo-soo Kim, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hyo-soo Kim, MD, PhD</last_name>
    <phone>+82-2-2072-2226</phone>
    <email>hyosoo@snu.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kosin University Gospel Hospital</name>
      <address>
        <city>Busan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeong Ho Heo</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Soon Chun Hyang University Hospital Cheonan</name>
      <address>
        <city>Cheonan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dong-Kyo Jin, MD,PhD</last_name>
      <email>bluesky@schch.co.kr</email>
    </contact>
    <investigator>
      <last_name>Dong-Kyu Jin, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chungbuk National University Hospital</name>
      <address>
        <city>Chonju</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jang-Hwan Bae, MD,PhD</last_name>
      <email>drcorazon@hanmail.net</email>
    </contact>
    <investigator>
      <last_name>Jang-Hwan Bae, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Myongji Hospital</name>
      <address>
        <city>Goyang</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deok-Kyu Cho</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gwangju Christian Hospital</name>
      <address>
        <city>Gwangju</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seung Uk Lee</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kwangju Veterans Hospital</name>
      <address>
        <city>Gwangju</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Won Kim, MD,PhD</last_name>
      <email>mylovekw@hanmail.net</email>
    </contact>
    <investigator>
      <last_name>Won Kim, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Presbyterian Medical Center</name>
      <address>
        <city>Jeonju</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Je-Young Rhew, MD,PhD</last_name>
      <email>jkrhew@hanafos.com</email>
    </contact>
    <investigator>
      <last_name>Je-Young Rhew, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gyeongsang National University Hospital</name>
      <address>
        <city>Jinju</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Choong-Hwan Cwak, MD,PhD</last_name>
      <email>cwakch@korea.com</email>
    </contact>
    <investigator>
      <last_name>Choong-Hwan Cwak, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pusan National University Hospital</name>
      <address>
        <city>Pusan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Han-Cheol Lee, MD,PhD</last_name>
      <email>glaraone@hanmail.net</email>
    </contact>
    <investigator>
      <last_name>Han-Cheol Lee, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dong-Ju Choi, MD,PhD</last_name>
      <email>djchoi@snu.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Dong-Ju Choi, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gangbuk Samsung Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jin-Ho Kang, MD,PhD</last_name>
      <email>jinho2.kang@samsung.com</email>
    </contact>
    <investigator>
      <last_name>Jin-Ho Kang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gangnam Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hyuk-Moon Kwon, MD,PhD</last_name>
      <email>kwonhm@yuhs.ac</email>
    </contact>
    <investigator>
      <last_name>Hyuk-Moon Kwon, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hyun-Cheol Kwon, MD,PhD</last_name>
      <email>hcgwon@skku.edu</email>
    </contact>
    <investigator>
      <last_name>Hyun-Cheol Kwon, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hyo-Soo Kim, MD, PhD</last_name>
      <phone>82-2-2072-2226</phone>
      <email>hyosoo@snu.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Hyo-soo Kim, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bon-Kwon Koo, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hyun-Jae Kang, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hae-Young Lee, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hyun-Jae Cho, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kyung-Woo Park, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Han-Mo Yang, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jung-Kyu Han, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sang-Eun Lee, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Soonchunhyang University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Min-Soo Hyon, MD,PhD</last_name>
      <email>mshyon@hosp.sch.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Min-Soo Hyon, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Vincent's Hospital</name>
      <address>
        <city>Suwon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Geon-Woong Moon, MD,PhD</last_name>
      <email>cardiomoon@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Geon-Woong Moon, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 21, 2016</study_first_submitted>
  <study_first_submitted_qc>May 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 12, 2017</study_first_posted>
  <last_update_submitted>May 10, 2017</last_update_submitted>
  <last_update_submitted_qc>May 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Hyo-Soo Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>coronary artery disease</keyword>
  <keyword>percutaneous coronary intervention</keyword>
  <keyword>zotarolimus-eluting stents</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Angina Pectoris</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sirolimus</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

